Boardroom Alpha
Boardroom Alpha
MTW · Current Report (Form 8-K) · Filed March 30, 2026

Manitowoc Co Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 30, 2026
Period
Mar 27, 2026
Ticker
MTW
Accession
0001193125-26-130512
Boardroom Alpha · Filing insights

James S. Cook resigns as Manitowoc's EVP, HR; transitions through June 19, 2026, with COBRA coverage through Sept 30, 2026.

About Manitowoc Co Inc
Market cap
$441M
1Y TSR
+9.9%
3Y TSR
−10.7%
Board grade
C
Sector
Industrials
CEO
Aaron H Ravenscroft
Last annual meeting: May 5, 2026 · View full Manitowoc Co Inc profile →
8-K

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 27, 2026

 

 

The Manitowoc Company, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Wisconsin

1-11978

39-0448110

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

11270 West Park Place

Suite 1000

 

Milwaukee, Wisconsin

 

53224

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 414 760-4600

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $.01 Par Value

 

MTW

 

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 27, 2026, James S. Cook resigned, effective as of March 29, 2026, from his position as Executive Vice President, Human Resources of The Manitowoc Company, Inc. (the “Company”), and, effective as of June 19, 2026 (the “Separation Date”), from his transitional employment with the Company.

 

In connection with his resignation, on March 27, 2026, the Company entered into a separation agreement (the “Agreement”) with Mr. Cook. Pursuant to the Agreement, during a transition period beginning on March 29, 2026 and ending on the Separation Date, Mr. Cook will continue to be employed by the Company to perform transitionary tasks at the Company’s request, subject to any approved leaves of absence. Mr. Cook will receive base salary and health insurance benefits during the transition period, but he will not be eligible to receive or vest in any additional equity-based or other incentive compensation during or following the transition period.

 

Following the Separation Date, if Mr. Cook timely elects COBRA coverage with respect to health insurance benefits, the Company will pay for the employer portion of the cost of such coverage for Mr. Cook and his eligible dependents through September 30, 2026, contingent on Mr. Cook providing a release of claims and continuing to comply with the Agreement.

 

The Agreement also includes a customary release of claims and restrictive covenants. However, following the Separation Date, Mr. Cook will be released from certain non-compete and non-solicitation obligations under his employment agreement.

 

 

2

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

THE MANITOWOC COMPANY, INC.

 

 

 

 

Date:

March 30, 2026

By:

/s/ Jennifer L. Paterson

 

 

 

Jennifer L. Peterson
Executive Vice President, General Counsel and Secretaty

 

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Manitowoc Co Inc (MTW)

Reference

Frequently asked questions

When did Manitowoc Co Inc file this 8-K?
Manitowoc Co Inc (MTW) filed this Current Report (Form 8-K) with the SEC on March 30, 2026. The accession number assigned by EDGAR is 0001193125-26-130512.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
James S. Cook resigns as Manitowoc's EVP, HR; transitions through June 19, 2026, with COBRA coverage through Sept 30, 2026. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Manitowoc Co Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Manitowoc Co Inc has filed under CIK 61986, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer